Cancer risk associated with anti-TIF1 antibodies

被引:0
|
作者
Collison J.
机构
[1] Nature Reviews Rheumatology,
关键词
D O I
10.1038/s41584-019-0164-3
中图分类号
学科分类号
摘要
[No abstract available]
引用
收藏
页码:64 / 64
相关论文
共 50 条
  • [21] A rare intersection: squamous cell carcinoma of the tonsil and the anti-TIF1 syndrome masquerade
    Sondhi, Manush
    Lear, Megan
    Dar, Saleha
    Tariq, Madiha
    BMC RHEUMATOLOGY, 2025, 9 (01)
  • [22] Analysis of the risk of cancer among myositis patients without anti-TIF1-γ OR -HMGCR antibodies
    Unuma, A.
    Kadoya, M.
    Hida, A.
    Taira, K.
    Uchio, N.
    Ikenaga, C.
    Kubota, A.
    Tsuji, S.
    Shimizu, J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 268 - 268
  • [23] Machine Learning Algorithms Identify Clinical Subtypes and Cancer in Anti-TIF1γ+ Myositis: A Longitudinal Study of 87 Patients
    Zhao, Lijuan
    Xie, Shuoshan
    Zhou, Bin
    Shen, Chuyu
    Li, Liya
    Pi, Weiwei
    Gong, Zhen
    Zhao, Jing
    Peng, Qi
    Zhou, Junyu
    Peng, Jiaqi
    Zhou, Yan
    Zou, Lingxiao
    Song, Liang
    Zhu, Honglin
    Luo, Hui
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [24] Association Study Between anti-TIF1γ Antibody and Development of Neoplasia in Three Tertiary Hospitals
    Pavia Pascual, Marina
    Jarque Canalias, Isidro
    Luis Morell, Jose
    Loarce Martos, Jesus
    Montano Tapia, Lorena
    Rusinovich, Olga
    de la Torre-Rubio, Natalia
    Machattou, Maria
    Navarro Palomo, Pablo
    Barbadillo Mateos, Maria Carmen
    Fernandez Castro, Monica
    Garcia-Magallon, Blanca
    Godoy Tundidor, Maria Hildegarda
    Merino, Carolina
    Sanz Sanz, Jesus
    Luis Andreu, Jose
    Campos, Jose
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3721 - 3723
  • [25] Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis
    Nakanishi, Yu
    Yamaguchi, Kakuhiro
    Yoshida, Yusuke
    Sakamoto, Shinjiro
    Horimasu, Yasushi
    Masuda, Takeshi
    Nakashima, Taku
    Miyamoto, Shintarou
    Iwamoto, Hiroshi
    Hirata, Shintaro
    Fujitaka, Kazunori
    Hamada, Hironobu
    Sugiyama, Eiji
    Hattori, Noboru
    INTERNAL MEDICINE, 2020, 59 (20) : 2553 - 2558
  • [26] Erythrodermic dermatomyositis with anti-TIF1-γ antibodies
    Tang, Ke-yun
    Jin, Hong-zhong
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024, 63 (09) : 1274 - 1276
  • [27] TRIM33 gene somatic mutations identified by next generation sequencing in neoplasms of patients with anti-TIF1γ positive cancer-associated dermatomyositis
    Cordel, Nadege
    Derambure, Celine
    Coutant, Sophie
    Mariette, Xavier
    Jullien, Denis
    Debarbieux, Sebastien
    Chosidow, Olivier
    Meyer, Alain
    Bessis, Didier
    Joly, Pascal
    Mathian, Alexis
    Levesque, Herve
    Sabourin, Jean-Christophe
    Tournier, Isabelle
    Boyer, Olivier
    RHEUMATOLOGY, 2021, 60 (12) : 5863 - 5867
  • [28] Occurrence of cholangiocarcinoma, three years after negative seroconversion of anti-TIF1γ antibody, in a dermatomyositis patient
    Ken Horisaki
    Yoshinao Muro
    Mariko Ogawa-Momohara
    Yuta Yamashita
    Haruka Koizumi
    Takuya Takeichi
    Masashi Akiyama
    European Journal of Dermatology, 2023, 33 : 48 - 49
  • [29] Remission of anti-TIF1γ dermatomyositis after allogeneic hematopoietic stem cell transplant for myelodysplastic syndrome
    Bawany, Fatima
    Tbakhi, Bushra
    Mendler, Jason H.
    Richardson, Christopher T.
    Bennett, John M.
    Aljitawi, Omar S.
    BLOOD ADVANCES, 2020, 4 (22) : 5698 - 5701
  • [30] Occurrence of cholangiocarcinoma, three years after negative seroconversion of anti-TIF1γ antibody, in a dermatomyositis patient
    Horisaki, Ken
    Muro, Yoshinao
    Ogawa-Momohara, Mariko
    Yamashita, Yuta
    Koizumi, Haruka
    Takeichi, Takuya
    Akiyama, Masashi
    EUROPEAN JOURNAL OF DERMATOLOGY, 2023, 33 (01) : 48 - 49